Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0000711377-17-000028)

Filing Details

Accession Number:
0000711377-17-000028
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-06 16:07:18
Reporting Period:
2017-10-04
Accepted Time:
2017-10-06 16:07:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1517426 J. Steven Quinlan 620 Lesher Place
Lansing MI 48912		 Vp & Cfo No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-10-04 2,250 $28.67 12,353 No 4 M Direct
Common Stock Disposition 2017-10-04 2,250 $78.52 10,103 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2017-10-04 2,250 $0.00 2,250 $28.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
79,700 2017-10-04 No 4 M Direct
Footnotes
  1. Options were granted 10/4/2012, have 5 year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant